To assess risk factors associated with systemic lupus erythematosus (SLE) in the Mexican population.
Material and methods
A case-control study was conducted on June 1996, at the Reumathology Clinic of Hospital de Especialidades del Centro Médico Nacional Siglo XXI (HE CMN), Instituto Mexicano del Seguro Social, in Mexico City. Cases were one hundred thirty subjects with four or more SLE criteria and disease evolution of +/- 5 years. Controls were hospitalized patients with acute diseases but without autoimmune diseases. Cases and controls were matched 1:1 by age and gender; both groups were evaluated by direct interview through a structured questionnaire. The following risk factors were assessed: genetic family history of SLE and connective tissue disease; socioedemographic (ethnicity, geographic distribution, education, monthly income); hormonal (use of oral contraceptives, replacement therapy and gynecoobstetric background); environmental (use of hair products, living with dogs, bacterial/viral infections, and allergies). Statistical analysis consisted of odd ratios (OR) with 95% confidence intervals (CI) and multivariate analysis using logistic regression.
Results
The multivariate model showed association with family history of SLE (OR 4.2, CI 95% 1.17-15.2), family history of connective tissue disorder (OR 2.6, CI 95% 1.15-4.5), use of oral contraceptives for more than one year (OR 2.1, CI 95% 1.13-4.3), repetitive pharyngitis (OR 2.1, CI 95% 1.18-3.6), and use of medications (OR 5.0 IC 95% 1.62-21.6). No association was found with socieconomic status, hair dye products, asthma, or allergies.
Conclusions
Genetic factors, such as family history of SLE and connective tissue disease in first-degree relatives, persist as important factors in the development of SLE. Other factors, such as use of some drugs, oral contraceptives, and repetitive pharyngitis, may also favor the onset of disease in genetically susceptible hosts. The English version of this paper is available at: http://www.insp.mx/salud/index.html.
oral contraceptives systemic lupus risk, hormonal contraception autoimmune disease, birth control pills lupus connection, contraceptive side effects autoimmune, sle risk factors women, systemic lupus erythematosus contraception, oral contraceptive complications, hormonal birth control immune effects, contraceptive use connective tissue disease, pharyngitis lupus association, genetic factors autoimmune disease, family history sle risk
Cite this article
Zonana-Nacach, A., Rodríguez-Guzmán, L. M., Jiménez-Balderas, F. J., Camargo-Coronel, A., Escobedo, J., & Fraga, A. (2002). [Risk factors associated with systemic lupus erythematosis in a Mexican population]. *Salud publica de Mexico*, *44*(3), 213-218.
Zonana-Nacach A, Rodríguez-Guzmán LM, Jiménez-Balderas FJ, Camargo-Coronel A, Escobedo J, Fraga A. [Risk factors associated with systemic lupus erythematosis in a Mexican population]. Salud Publica Mex. 2002;44(3):213-218.
Zonana-Nacach, Abraham, et al. "[Risk factors associated with systemic lupus erythematosis in a Mexican population]." *Salud publica de Mexico*, vol. 44, no. 3, 2002, pp. 213-218.
Background: The incidence of multiple sclerosis (MS) is rising in women. Objective: To determine whether the use of combined oral contraceptives (COCs) are associated with MS risk and whether this var...
van Bommel MHD et al., 2022
Free to Read
Human reproduction update
Background: Increasing numbers of BReast CAncer (BRCA) 1 or 2 pathogenic variant (PV) carriers, who have an inherited predisposition to breast and ovarian cancer, are being identified. Among these wom...
Background: Epigenetic changes, geography and environmental factors do surpass the genetic factors in the development of breast cancer. This study investigates the association of reproductive factors ...
Background: The incidence of breast cancer is on the rise in India, breast cancer is the second most common malignancy in Indian women. Aim: The aim of this study was to find out the association of va...
General OB/GYN > Epidemiology > Risk FactorsContraception/Comparison > Side Effects > Hormonal Contraception